Foreign Drug Giants Undercut by Up to 95% in China Bidding War

(Bloomberg) -- Global drugmakers from Merck & Co. to Novartis AG lost another slice of their lucrative China business, as domestic competitors undercut them with bids more than 95% lower to supply ...